Akèy › Gliyòm › Washington › Seattle

Etid klinik pou Gliyòm nan Seattle, WA

11 etid pou Gliyòm ap chèche patisipan nan sit nan ak bò kote Seattle (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Ap rekriteFaz 1/2

Seattle Children's Hospital, Seattle

12 Months – 21 Years · Tout sèks · Mizajou Oct 1, 2026 · NCT05099003

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Ap rekriteFaz 2

Seattle Children's Hospital, Seattle

12 Months – 39 Years · Tout sèks · Mizajou Sep 21, 2026 · NCT06838676

Targeted Pediatric High-Grade Glioma Therapy

Ap rekriteEtid obsèvasyon

Seattle Children's Hospital, Seattle

12 Months – 39 Years · Tout sèks · Mizajou Sep 8, 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

Ap rekriteFaz 2

Seattle Children's Hospital, Seattle

Laj 12 a 39 · Tout sèks · Mizajou Sep 1, 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Ap rekriteFaz 3

Fred Hutch Cancer Center, Seattle

Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT05303519

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Ap rekriteFaz 2

Seattle Children's Hospital, Seattle

Laj 3 a 39 · Tout sèks · Mizajou Aug 24, 2026 · NCT05096481

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Ap rekriteFaz 2

University of Washington School of Medicine, Seattle

Laj 8 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05503797

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Ap rekriteFaz 1 bonèVolontè an sante akeyi

Seattle Children's Hospital, Seattle

Laj 1 a 21 · Tout sèks · Mizajou Jun 29, 2026 · NCT06333899

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Ap rekriteFaz 2

Seattle Children's Hospital, Seattle

12 Months – 39 Years · Tout sèks · Mizajou May 29, 2026 · NCT05843253

Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors

Ap rekriteFaz 1

Seattle Children's Hospital, Seattle

Laj 1 a 26 · Tout sèks · Mizajou Apr 13, 2026 · NCT04185038

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

Ap rekriteFaz 1 bonè

Seattle Children's Hospital, Seattle

Jiska laj 21 · Tout sèks · Mizajou Mar 18, 2026 · NCT04655404

Etid Gliyòm nan lòt vil

Lòt etid nan Seattle

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.